This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ceres Announces Fiscal First Quarter 2013 Financial Results


This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding our efforts to develop and commercialize our products, our short-term and long-term business strategies, market and industry expectations, future operating metrics, product yields and future results of operations and financial position, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control. Factors that could materially affect actual results can be found in Ceres’ filings with the U.S. Securities and Exchange Commission. Ceres undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Ceres’ views as of any date subsequent to the date of this press release.

Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
  Three Months Ended
November 30,
2012   2011
Product sales $ 14 $ 276
Collaborative research and government grants   1,952     1,472  
Total revenues   1,966     1,748  
Cost and operating expenses:
Cost of product sales 700 763
Research and development 4,343 5,275
Selling, general and administrative   3,844     2,804  
Total cost and operating expenses   8,887     8,842  
Loss from operations (6,921 ) (7,094 )
Interest expense (1 ) (111 )
Interest income 29 4
Other expense       (338 )
Loss before income taxes (6,893 ) (7,539 )
Income tax (expense) benefit   (1 )   (1 )
Net loss $ (6,894 ) $ (7,540 )
Basic and diluted net loss per share $ (0.28 ) $ (3.73 )
Basic and diluted weighted average outstanding

common shares used for net loss per share

24,693,303 2,018,939
Condensed Consolidated Balance Sheets
(In thousands, except share amounts)
  November 30,   August 31,
2012 2012
Current assets:
Cash and cash equivalents $ 14,378 $ 21,069
Marketable securities 37,636 33,565
Prepaid expenses 758 1,050
Accounts receivable 1,488 765
Inventories 1,054 841
Other current assets   144     278  
Total current assets   55,458     57,568  
Property and equipment, net 5,559 5,756
Marketable securities 1,156 5,720
Other assets   105     203  
Total long-term assets   6,820     11,679  
Total assets $ 62,278   $ 69,247  

Liabilities and Stockholders’ Equity

Current liabilities:
Accounts payable and accrued expenses $ 5,314 $ 5,476
Other current liabilities 345 732
Current portion of long-term debt   65     134  
Total current liabilities 5,724 6,342
Other non-current liabilities 69 88
Long-term debt, net of current portion   96     256  
Total liabilities   5,889     6,686  
Commitments and contingencies
Stockholders’ (deficit) equity:
Common stock and additional paid in capital, $0.01 par value; 490,000,000 shares authorized; 24,801,986 shares issued and outstanding at November 30, 2012; 24,549,029 shares issued and outstanding at August 31, 2012. 305,740 304,917
Accumulated other comprehensive loss (384 ) (283 )
Accumulated deficit   (248,967 )   (242,073 )
Total stockholders’ (deficit) equity   56,389     62,561  
Total liabilities, convertible preferred stock and stockholders’ (deficit) equity $ 62,278   $ 69,247  

4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community


DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs